Income Tax Expense (Benefit) in USD of NovoCure Ltd from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
NovoCure Ltd quarterly/annual Income Tax Expense (Benefit) history and change rate from 2013 to Q3 2025.
  • NovoCure Ltd Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $7,248,000.000, a 19.3% decline year-over-year.
  • NovoCure Ltd Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $27,148,000.000, a 23.1% decline year-over-year.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2024 was $37,465,000.000, a 145% increase from 2023.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2023 was $15,303,000.000, a 43.2% increase from 2022.
  • NovoCure Ltd annual Income Tax Expense (Benefit) for 2022 was $10,688,000.000, a 70.3% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)

NovoCure Ltd Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $27,148,000 $7,248,000 -$1,737,000 -19.3% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $28,885,000 $5,160,000 -$5,486,000 -51.5% 01 Apr 2025 30 Jun 2025 10-Q 24 Jul 2025
Q1 2025 $34,371,000 $4,024,000 -$3,094,000 -43.5% 01 Jan 2025 31 Mar 2025 10-Q 24 Apr 2025
Q4 2024 $37,465,000 $10,716,000 +$2,171,000 +25.4% 01 Oct 2024 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $35,294,000 $8,985,000 +$7,722,000 +6.1% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 $27,572,000 $10,646,000 +$7,132,000 +2% 01 Apr 2024 30 Jun 2024 10-Q 24 Jul 2025
Q1 2024 $20,440,000 $7,118,000 +$5,137,000 +2.6% 01 Jan 2024 31 Mar 2024 10-Q 24 Apr 2025
Q4 2023 $15,303,000 $8,545,000 +$3,800,000 +80.1% 01 Oct 2023 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $11,503,000 $1,263,000 -$1,896,000 -60% 01 Jul 2023 30 Sep 2023 10-Q 30 Oct 2024
Q2 2023 $13,399,000 $3,514,000 +$2,862,000 +4.4% 01 Apr 2023 30 Jun 2023 10-Q 25 Jul 2024
Q1 2023 $10,537,000 $1,981,000 -$151,000 -7.1% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $10,688,000 $4,745,000 +$3,860,000 +4.4% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025
Q3 2022 $6,828,000 $3,159,000 +$568,000 +21.9% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023
Q2 2022 $6,260,000 $652,000 -$754,000 -53.6% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023
Q1 2022 $7,014,000 $2,132,000 +$738,000 +52.9% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $6,276,000 $885,000 -$3,023,000 -77.4% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024
Q3 2021 $9,299,000 $2,591,000 +$836,000 +47.6% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022
Q2 2021 $8,463,000 $1,406,000 -$990,000 -41.3% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022
Q1 2021 $9,453,000 $1,394,000 +$11,159,000 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022
Q4 2020 -$1,706,000 $3,908,000 +$9,760,000 01 Oct 2020 31 Dec 2020 10-K 23 Feb 2023
Q3 2020 -$11,466,000 $1,755,000 +$2,385,000 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021
Q2 2020 -$13,851,000 $2,396,000 +$1,169,000 +95.3% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021
Q1 2020 -$15,020,000 -$9,765,000 -$13,426,000 -3.7% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q4 2019 -$1,594,000 -$5,852,000 -$10,659,000 -2.2% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022
Q3 2019 $9,065,000 -$630,000 -$4,681,000 -1.2% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020
Q2 2019 $13,746,000 $1,227,000 -$4,338,000 -78% 01 Apr 2019 30 Jun 2019 10-Q/A 02 Oct 2020
Q1 2019 $18,084,000 $3,661,000 +$467,000 +14.6% 01 Jan 2019 31 Mar 2019 10-Q/A 02 Oct 2020
Q4 2018 $17,617,000 $4,807,000 +$752,000 +18.5% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 $16,865,000 $4,051,000 +$628,000 +18.3% 01 Jul 2018 30 Sep 2018 10-Q 31 Oct 2019
Q2 2018 $16,237,000 $5,565,000 +$2,104,000 +60.8% 01 Apr 2018 30 Jun 2018 10-Q 25 Jul 2019
Q1 2018 $14,133,000 $3,194,000 +$968,000 +43.5% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q4 2017 $13,165,000 $4,055,000 +$2,618,000 +1.8% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020
Q3 2017 $10,547,000 $3,423,000 +$249,000 +7.8% 01 Jul 2017 30 Sep 2017 10-Q 25 Oct 2018
Q2 2017 $10,298,000 $3,461,000 +$641,000 +22.7% 01 Apr 2017 30 Jun 2017 10-Q 26 Jul 2018
Q1 2017 $9,657,000 $2,226,000 -$724,000 -24.5% 01 Jan 2017 31 Mar 2017 10-Q 26 Apr 2018
Q4 2016 $10,381,000 $1,437,000 -$10,000 -0.69% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019
Q3 2016 $10,391,000 $3,174,000 +$2,198,000 +2.3% 01 Jul 2016 30 Sep 2016 10-Q 26 Oct 2017
Q2 2016 $8,193,000 $2,820,000 +$1,545,000 +1.2% 01 Apr 2016 30 Jun 2016 10-Q 27 Jul 2017
Q1 2016 $6,648,000 $2,950,000 +$2,214,000 +3% 01 Jan 2016 31 Mar 2016 10-Q 27 Apr 2017
Q4 2015 $4,434,000 $1,447,000 01 Oct 2015 31 Dec 2015 10-K 22 Feb 2018
Q3 2015 $976,000 +$614,000 +1.7% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $1,275,000 01 Apr 2015 30 Jun 2015 10-Q 28 Jul 2016
Q1 2015 $736,000 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q3 2014 $362,000 01 Jul 2014 30 Sep 2014 10-Q 27 Oct 2015

NovoCure Ltd Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $37,465,000 +$22,162,000 +1.4% 01 Jan 2024 31 Dec 2024 10-Q 30 Oct 2025
2023 $15,303,000 +$4,615,000 +43.2% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025
2022 $10,688,000 +$4,412,000 +70.3% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025
2021 $6,276,000 +$7,982,000 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024
2020 -$1,706,000 -$112,000 -7% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023
2019 -$1,594,000 -$19,211,000 -1.1% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022
2018 $17,617,000 +$4,452,000 +33.8% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $13,165,000 +$2,784,000 +26.8% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $10,381,000 +$5,947,000 +1.3% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019
2015 $4,434,000 +$4,052,000 +10.6% 01 Jan 2015 31 Dec 2015 10-K 22 Feb 2018
2014 $382,000 +$29,000 +8.2% 01 Jan 2014 31 Dec 2014 10-K 23 Feb 2017
2013 $353,000 01 Jan 2013 31 Dec 2013 10-K 01 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.